36P A point mutation replacing cysteine with arginine at position 382 (C382R) in the transmembrane domain of FGFR2 leads to response to FGF2-inhibitor pemigatinib in chemo-refractory intrahepatic cholangiocarcinoma [Abstract]
Author: | L. C. Hempel, Constantin LapaORCiDGND, A. Gaumann, J. Veloso de Oliveira, J. Scheiber, P. Philipp, C. Oyarzun, S. Wesarg, S. Robert, D. Hempel |
---|---|
Frontdoor URL | https://opus.bibliothek.uni-augsburg.de/opus4/123358 |
ISSN: | 0923-7534OPAC |
Parent Title (English): | Annals of Oncology |
Publisher: | Elsevier BV |
Place of publication: | Amsterdam |
Type: | Article |
Language: | English |
Year of first Publication: | 2022 |
Publishing Institution: | Universität Augsburg |
Release Date: | 2025/07/18 |
Volume: | 33 |
Issue: | Supplement 1 |
First Page: | S17 |
DOI: | https://doi.org/10.1016/j.annonc.2022.01.045 |
Institutes: | Medizinische Fakultät |
Medizinische Fakultät / Universitätsklinikum | |
Medizinische Fakultät / Lehrstuhl für Nuklearmedizin |